Suppr超能文献

对22q11.2缺失综合征患者的miRNA进行下一代测序分析,结果显示miR-185-5p的表达发生了改变。

Next-generation sequencing profiling of miRNAs in individuals with 22q11.2 deletion syndrome revealed altered expression of miR-185-5p.

作者信息

Dantas Anelisa Gollo, Nunes Beatriz Carvalho, Nunes Natália, Galante Pedro, Asprino Paula Fontes, Ota Vanessa Kiyomi, Melaragno Maria Isabel

机构信息

Genetics Division, Department of Morphology and Genetics, Universidade Federal de São Paulo, São Paulo, Brazil.

Department of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.

出版信息

Hum Genomics. 2024 Jun 13;18(1):64. doi: 10.1186/s40246-024-00625-5.

Abstract

BACKGROUND

The 22q11.2 deletion syndrome (22q11.2DS) is a microdeletion syndrome with highly variable phenotypic manifestations, even though most patients present the typical 3 Mb microdeletion, usually affecting the same ~ 106 genes. One of the genes affected by this deletion is DGCR8, which plays a crucial role in miRNA biogenesis. Therefore, the haploinsufficiency of DGCR8 due to this microdeletion can alter the modulation of the expression of several miRNAs involved in a range of biological processes.

RESULTS

In this study, we used next-generation sequencing to evaluate the miRNAs profiles in the peripheral blood of 12 individuals with typical 22q11DS compared to 12 healthy matched controls. We used the DESeq2 package for differential gene expression analysis and the DIANA-miTED dataset to verify the expression of differentially expressed miRNAs in other tissues. We used miRWalk to predict the target genes of differentially expressed miRNAs. Here, we described two differentially expressed miRNAs in patients compared to controls: hsa-miR-1304-3p, located outside the 22q11.2 region, upregulated in patients, and hsa-miR-185-5p, located in the 22q11.2 region, which showed downregulation. Expression of miR-185-5p is observed in tissues frequently affected in patients with 22q11DS, and previous studies have reported its downregulation in individuals with 22q11DS. hsa-miR-1304-3p has low expression in blood and, thus, needs more validation, though using a sensitive technology allowed us to identify differences in expression between patients and controls.

CONCLUSIONS

Thus, lower expression of miR-185-5p can be related to the 22q11.2 deletion and DGCR8 haploinsufficiency, leading to phenotypic consequences in 22q11.2DS patients, while higher expression of hsa-miR-1304-3p might be related to individual genomic variances due to the heterogeneous background of the Brazilian population.

摘要

背景

22q11.2缺失综合征(22q11.2DS)是一种微缺失综合征,其表型表现高度可变,尽管大多数患者存在典型的3 Mb微缺失,通常影响相同的约106个基因。受此缺失影响的基因之一是DGCR8,它在miRNA生物合成中起关键作用。因此,由于这种微缺失导致的DGCR8单倍体不足可改变参与一系列生物过程的几种miRNA表达的调节。

结果

在本研究中,我们使用下一代测序技术评估了12名典型22q11DS患者外周血中的miRNA谱,并与12名健康匹配对照进行比较。我们使用DESeq2软件包进行差异基因表达分析,并使用DIANA-miTED数据集验证其他组织中差异表达miRNA的表达。我们使用miRWalk预测差异表达miRNA的靶基因。在此,我们描述了与对照相比患者中两个差异表达的miRNA:位于22q11.2区域外的hsa-miR-1304-3p在患者中上调,位于22q11.2区域的hsa-miR-185-5p则显示下调。在22q11DS患者经常受影响的组织中观察到miR-185-5p的表达,并且先前的研究报道其在22q11DS个体中下调。hsa-miR-1304-3p在血液中表达较低,因此需要更多验证,尽管使用敏感技术使我们能够识别患者和对照之间的表达差异。

结论

因此,miR-185-5p的低表达可能与22q11.2缺失和DGCR8单倍体不足有关,导致22q11.2DS患者出现表型后果,而hsa-miR-1304-3p的高表达可能与巴西人群异质背景导致的个体基因组变异有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5a6/11170780/456a3fddca82/40246_2024_625_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验